State governments will be able to purchase Covaxin for 600 rs per dose, while private hospitals will be able to purchase it for 1,200 rs per dose, according to Bharat Biotech, a Hyderabad-based group.

“We announce the prices of COVAXIN vaccines, which are 600 per dose for state hospitals and 1,200 per dose for corporate hospitals Bharat Biotech said, citing government directives.

Covaxin will also be exported, according to the vaccine producer, and the export price will be between $15 and $20 (roughly $1,123 to 1,498 USD).

Recovering costs is key in the path of discovery towards other vaccines such as Intranasal Covid-19,” Bharat Biotech chairman and managing director Krishna M Ella said in a statement. Over the past 25 years, our primary goal has been to bring sustainable, world-class healthcare options to people all over the world.

The Hyderabad-based company also said that the current Covid-19 pandemic in India and the rest of the world is “deeply concerning.

Bharat Biotech is proud to produce, manufacture, and supply Covaxin for the Government of India’s vaccine launch, which costs Rs 150 per dose and is distributed for free. “We’d like to point out that more than half of our capacity has been set aside for central government supplies,” the statement continued.

Serum Institute of India, India’s other vaccine manufacturer, will supply Covishield to states for $400 per shot and private hospitals for $600 per injection.

On April 19, the government introduced a “liberalized” scheme, allowing everyone above the age of 18 to get vaccinated beginning May 1. That’s also made it possible for state governments and private hospitals to buy vaccines directly from suppliers.

According to a PTI study, manufacturers of Covid-19 vaccines will be able to sell 50 percent doses to state governments and on the open market, but they will have to make an advance price declaration before 1 May.

On January 16, India launched the Covid vaccination campaign, which included two vaccines: Covishield and Covaxin.

On March 1, the second phase of the coronavirus vaccine program to inoculate people over 60 and others over 45 with comorbidities began. The third process started on April 1st for those above the age of 45.

All above the age of 18 will be able to collect the dose in the next round, which begins on May 1st.